Skip navigation AI for drug development: Experts break down what’s possible — and what’s just hype

STAT reporter, Casey Ross, leads a thought-provoking conversation with key industry experts about how drug developers, doctors, and bioinformatics researchers are using artificial intelligence to revolutionize the search for breakthrough therapies.

Hear from Niven R. Narain, PhD., BERG’s Co-Founder, President and CEO and other industry leaders.

For the full panel session, click here.